- Home
- » e-Newsletters
FDA warns of arthritis drugs infection risk
Infection Control Monitor, September 12, 2008
The Food and Drug Administration (FDA) on September 4 ordered stronger warnings on four medications widely used to treat rheumatoid arthritis, saying the drugs can raise the risk of developing opportunistic fungal infections.
The four medications are Enbrel, Remicade, Humira, and Cimzia. The FDA said the manufacturers of the TNF-alpha blocker drugs must strengthen existing warnings. Some patients with invasive fungal infections have died, the agency said in a press release.
The drugs work by suppressing the immune system to keep it from the attacking the body. While they provide relief from swollen and painful joints for patients with rheumatoid arthritis, they also lower the body’s defenses to infections.
Based on reports it has reviewed, the FDA said healthcare professionals are not consistently recognizing cases of histoplasmosis and other invasive fungal infections, leading to delays in patient treatment. Patients taking TNF blockers, who develop a persistent fever, cough, shortness of breath, or fatigue, should seek medical attention, the FDA said. For more information, click here.
Most Popular
- Articles
-
- Q/A: Billing telemetry daily monitoring
- Credentialing monthly: What is the role of the credentials committee in addressing unprofessional conduct?
- 2010 ICD-9 code updates now available online
- Master modifiers to ensure accurate reimbursement
- H1N1 hits Maine facility
- Radiologist indicted for fraudulently signing reports
- Don’t be scared into silence: Affiliation letter safeguards allow you to disclose more
- National Quality Forum creates standardized set of data for electronic health records
- New report reveals $47 billion in Medicare fraud
- Understand the H1N1 Flu and how to code it
- E-mailed
-
- Credentialing monthly: What is the role of the credentials committee in addressing unprofessional conduct?
- Q/A: Billing telemetry daily monitoring
- Radiologist indicted for fraudulently signing reports
- Revised MS.1.20 'huge improvement', out for comment again
- H1N1 hits Maine facility
- New report reveals $47 billion in Medicare fraud
- Briefings on Outpatient Rehab Reimbursement and Regulations, December 2009
- Hand hygiene rates improved through variety of reinforcement styles
- Press Ganey report: Patient satisfaction increasing across the country
- Residency Program Alert, December 2009
- Searched